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We report that the mammalian 5-methylcytosine
(5mC) oxidase Tet3 exists as three major isoforms
and characterized the full-length isoform containing
an N-terminal CXXC domain (Tet3FL). This CXXC
domain binds to unmethylated CpGs, but, unexpect-
edly, its highest affinity is toward 5-carboxylcytosine
(5caC). We determined the crystal structure of the
CXXC domain-5caC-DNA complex, revealing the
structural basis of the binding specificity of this
domain as a reader of CcaCG sequences. Mapping
of Tet3FL in neuronal cells shows that Tet3FL is local-
ized precisely at the transcription start sites (TSSs) of
genes involved in lysosome function, mRNA pro-
cessing, and key genes of the base excision repair
pathway. Therefore, Tet3FL may function as a regu-
lator of 5caC removal by base excision repair. Active
removal of accumulating 5mC from the TSSs of
genes coding for lysosomal proteins by Tet3FL in
postmitotic neurons of the brain may be important
for preventing neurodegenerative diseases.
INTRODUCTION
5-Methylcytosine (5mC) is a modified cytosine base implicated
in gene control and has long been thought to be the only modi-
fied base present naturally in mammalian DNA (Klose and Bird,
2006). Only recently has 5-hydroxymethylcytosine (5hmC) also
been identified (Kriaucionis and Heintz, 2009; Tahiliani et al.,
2009). 5hmC is formed enzymatically by the Tet family of 5mC
oxidases (Tahiliani et al., 2009; Ito et al., 2010) and is now thought
to be a stable component of the epigenetic code (Koh and Rao,
2013; Pfeifer et al., 2013; Wu and Zhang, 2014). Alternatively,
5hmC has been viewed as an intermediate base in developmen-Ctally controlled DNA demethylation reactions. The two proposed
functions of 5hmC are not necessarily mutually exclusive (Hahn
et al., 2014).
Levels of 5hmC are particularly high in neuronal cells, where
they reach up to1% of all cytosines; for example, in the human
brain (M€unzel et al., 2010). The function of this base in neurons is
still unclear. Mapping studies have shown that 5hmC is localized
prominently within transcribed sequences of a number of
neuronal function-related genes (Szulwach et al., 2011; Hahn
et al., 2013). In the embryonic mouse brain, 5hmC formation
along important neuron-specific genes parallels neuronal differ-
entiation, and depletion of Tet2 and Tet3 leads to a block of
neuron migration, suggesting that 5hmC is important for brain
development (Hahn et al., 2013). Substantial levels of 5hmC
also occur at regions near promoters and enhancers; for
example, in embryonic stem cells (ESCs) (Kriaucionis andHeintz,
2009; Ficz et al., 2011; Williams et al., 2011). 5mC oxidation ap-
pears to be important in keeping such sequences in an unmethy-
lated state (Williams et al., 2011; Hahn et al., 2014). During other
developmental phases, when DNA methylation is erased glob-
ally, 5hmC can be viewed as a transiently existing base that pro-
motes DNA demethylation; e.g., in zygotes and primordial germ
cells (Gu et al., 2011; Iqbal et al., 2011; Wossidlo et al., 2011;
Hackett et al., 2013). Recent studies have dissected the contri-
bution of Tet3 to DNA demethylation in zygotes and concluded
that there are Tet3-dependent and Tet3-independent but repli-
cation-associated DNA demethylation events in the paternal
pronucleus of the zygote (Guo et al., 2014; Peat et al., 2014;
Shen et al., 2014).
The three related mammalian proteins Tet1, Tet2, and Tet3
all possess 5mC oxidase activity, but they differ in terms of
domain architecture and tissue specificity of their expression
levels (Tahiliani et al., 2009; Ito et al., 2010). For example,
although Tet1 and Tet2 mRNA levels are abundant in ESCs
and primordial germ cells (Ito et al., 2010; Ficz et al., 2011;
Gu et al., 2011; Hackett et al., 2013; Yamaguchi et al., 2013;
Huang et al., 2014), Tet3 is the only Tet gene expressed atell Reports 14, 493–505, January 26, 2016 ª2016 The Authors 493
Figure 1. Functional Characterization of
Different Tet3 Isoforms
(A) Schematic of the three Tet3 isoforms.
(B) Anti-V5 western blot of transfected Tet3 protein
isoforms.
(C) Immunofluorescence detection of 5hmC in
cells transfected with different Tet3 isoforms. Cells
were co-immunostained with anti-V5 tag antibody
(green) and anti-5hmC antibody (red). Scale bars,
20 mm.
(D) 5hmC production by Tet3 isoforms as analyzed
by anti-5hmC dot blot. Tet3FL-CXXC-DM, Tet3FL
with a CXXC domain double mutation (C60A and
C72A) deficient in DNA binding.
(E) Reactivation of a methylation-silenced lucif-
erase construct by Tet3 isoforms and by Tet3FL
containing the CXXC domain DNA binding muta-
tions (Tet3FL-CXXC-DM) in the absence or pres-
ence of sodium ascorbate.
(F) An unmethylated luciferase vector was used as
a control for (E).
See also Figure S1 and Table S1.substantial levels in oocytes and zygotes (Gu et al., 2011; Iqbal
et al., 2011; Wossidlo et al., 2011). Presumably, the Tet proteins
also show functional differences, but their specific properties
are currently not understood. The Tet1 and Tet3 5mC oxidases
are characterized by two conserved domains, an N-terminal
CXXC domain that binds to CpG dinucleotides and a C-termi-
nal Fe(II)- and 2-ketoglutarate-dependent catalytic domain
that progressively converts 5mC to 5hmC, 5-formylcytosine
(5fC), and, terminally, to 5-carboxylcytosine (5caC), resulting
in active or passive DNA demethylation (Tahiliani et al., 2009;
Ito et al., 2010, 2011; He et al., 2011; Shen et al., 2013; Hashi-
moto et al., 2014; Hu et al., 2014). Passive DNA demethylation
is achieved by the inability of the maintenance DNA methyl-
transferase Dnmt1 to copy the CpG methylation pattern at se-
quences that contain 5hmC (Valinluck and Sowers, 2007;
Hashimoto et al., 2012). Active demethylation can be accom-
plished by removal of 5fC or 5caC through thymine DNA glyco-
sylase (TDG)-initiated base excision repair (BER) (He et al.,
2011) or, perhaps alternatively, through a yet unidentified
5caC decarboxylase activity.
Here we focused on mouse Tet3 and characterized Tet3 func-
tion with special emphasis on its long isoform, which contains an
N-terminal CXXC domain. We found that the CXXC domain of
Tet3 has the capacity to bind to unmethylated and carboxylated
cytosines at CpG sequences and that full-length Tet3 has a very
restricted genomic localization patternwith a preference for tran-
scription start sites of a specific set of important genes in
neuronal cell populations.494 Cell Reports 14, 493–505, January 26, 2016 ª2016 The AuthorsRESULTS
Three Different Tet3 Transcript
Isoforms
Tet1 has a single transcript containing all
conserved domains. Tet2, however, has
lost its N-terminal CXXC domain, which
is now encoded by a separate, neigh-boring gene named Idax/Cxxc4 (Ko et al., 2013). Idax/Cxxc4
forms a complex with Tet2, negatively regulating its activity.
Tet3 possesses two known isoforms, one containing the CXXC
domain, to which we refer here as Tet3 full-length (Tet3FL),
and one lacking a CXXC domain, Tet3 short (Tet3s) (Figure 1A).
A recent study has indicated that the CXXC domain of Xenopus
tropicalis Tet3 (xtTet3) functions via binding to unmodified CpG
dinucleotides or cytosines (Xu et al., 2012). Interestingly, the level
of Xenopus Tet3 mRNA is very low in oocytes, and this may
explain the lack of genome-wide DNA demethylation in fertilized
Xenopus eggs, which, in mammals, involves Tet3-dependent
oxidation of 5-methylcytosines in the paternal genome after
fertilization (Gu et al., 2011; Iqbal et al., 2011; Wossidlo et al.,
2011). In contrast, upregulation ofmouse Tet3 and the accompa-
nying increase of 5hmC levels during neuronal differentiation
affects specific gene targets rather than the genome globally,
suggesting that Tet3 activity can be modulated based on a
cellular and genomic context (Hahn et al., 2013).
To characterize mammalian Tet3, we examined the transcripts
of Tet3FL and Tet3s using qRT-PCR with primer pairs spanning
the isoform-specific exons at the 50 end and measured the total
levels of Tet3 transcripts with primers spanning the conserved
30 exons (Figure S1; Table S1). Total levels of Tet3 were highly
abundant in oocytes (Figure S1D) and were upregulated during
retinoic acid-induced differentiation of mouse ESCs toward the
neuronal lineage (Figures S1E and S1F), consistent with previous
results (Ko et al., 2010; Iqbal et al., 2011). Analysis of
neuronal markers confirmed the progression of differentiation
(Figure S1G). Using 50-RACE with oocyte mRNA as well as
in silico searches of mouse oocyte EST databases, we identified
an undocumented variant of Tet3 in mouse oocytes. This tran-
script is created by alternative promoter use and contains
an additional N-terminal exon coding for 11 amino acids
(MFLPETPQQYA) (Figure S1A). The promoter is located approx-
imately 5 kb upstream of the start codon of the mouse Tet3FL
isoform but lacks the CXXC domain via alternative splicing (Fig-
ure 1A; Figure S1A). This Tet3 isoform was named Tet3o. Using
RT-PCR, we confirmed that there are no additional major spliced
Tet3 isoforms other than the three N-terminal variants, Tet3s,
Tet3FL, and Tet3o, in oocytes or neuronal cells (Figures S1B
and S1C). A Tet3FL isoform lacking both exons 1 and 2, as
described in a neural stem cell line (Liu et al., 2013a), was present
at less than 5% of total Tet3FL transcripts in the embryonic day
(E) 15.5 mouse embryo brain. Tet3s and Tet3FL were upregu-
lated during ES cell differentiation toward the neuronal lineage
(Figure S1F). Tet3o was not expressed in ESCs or in any other
cell type or adult mouse tissue tested (Figure S1F; data not
shown). Together, these data show that Tet3o is an oocyte-spe-
cific isoform of Tet3 that is predicted to be involved in preferential
global oxidation of the paternal genome in mouse zygotes (Gu
et al., 2011; Iqbal et al., 2011; Wossidlo et al., 2011), suggesting
different functions of Tet3 during early embryonic development
and in the neuronal lineage.
Characterization of Tet3 Isoforms
We next examined the subcellular localization and activity of
each Tet3 isoform in HEK293 cells using transient transfection
and immunofluorescence staining with anti-tag (V5) and anti-
5hmC antibodies (Figures 1B and 1C). The full-length V5-
epitope tagged variants of Tet3 were localized with increased
5hmC levels in the nucleus, indicating that they all function as
nuclear 5mC oxidases (Figure 1C). Tet3 isoform-induced
genome-wide 5mC oxidation activity was confirmed by mea-
surement of 5hmC levels in genomic DNA using immuno-dot
blots (Figure 1D). In these assays, Tet3FL had the lowest activ-
ity. We then used a reporter assay with a 5mC-silenced lucif-
erase vector where repression can be released because of
oxidation of 5mC via overexpressed Tet proteins in a vitamin
C dose-dependent manner (Figures 1E and 1F; Blaschke
et al., 2013; Minor et al., 2013; Yin et al., 2013). This in vivo assay
showed that all variants are functionally active and that the
oxidase activity of Tet3o and Tet3s can significantly relieve
5mC-induced repression of the luciferase reporter. However,
Tet3FL was substantially less effective than Tet3o and Tet3s
(Figure 1E). The different assays suggest that the CXXC domain
of Tet3 restricts its genome-wide 5mC oxidation capacity. Our
data are in apparent contrast to a previous report (Liu et al.,
2013a). Liu et al. (2013a) used an N-terminal GFP-tagged
version of Tet3FL. Our construct had a C-terminal V5 tag. In their
study, Liu et al. (2013a) showed that direct N-terminal tagging of
the Tet1 CXXC domain interferes with DNA binding. Because
the CXXC domain of Tet3 is directly at the N terminus, their
tagging approach presents a possible explanation for the
observed differences.
Our findings prompted us to investigate the biological proper-
ties of Tet30s CXXC domain. Two previous reports regarding theCrole of other CXXC domains have indicated that the CXXC
domain of DNMT1 can inhibit DNMT1 activity (Song et al.,
2011) and that overexpression of Idax/Cxxc4 is capable of
inducing caspase-dependent degradation of its binding partner,
Tet2 (Ko et al., 2013). To test whether the first of these CXXC
domain-dependent mechanisms could play a role in modulation
of Tet3 activity, we incubated the recombinant glutathione
S-transferase (GST)-tagged CXXC domain of Tet3 with a
HEK293 cell lysate expressing the catalytic domain of Tet3,
but no direct interaction between the CXXC domain and the cat-
alytic domain was observed (data not shown), although we
cannot exclude the possibility that such interactions may occur
in vivo. To test the second mechanism, caspase inhibitors
were added alongside overexpressed Tet3 variants, but this
had no specific effect on the protein quantity of the Tet3FL iso-
form (data not shown). We therefore hypothesized that the
CXXC DNA binding domain restricts the ability of the catalytic
domain of Tet3FL to oxidize 5mC globally by limiting its mobility
in the nucleus. To abolish the DNA binding, we generated CXXC
domain mutations (C60A and C72A) (Figure 2A) based on Tet1-
CXXC mutations shown to cause a loss of DNA binding (Xu
et al., 2011). The assays revealed that loss of DNA binding of
the CXXC domain increases the catalytic activity of Tet3FL (Fig-
ures 1D and 1E). Together, these data suggest that the CXXC
domain of mouse Tet3 restricts the in vivo activity of Tet3FL by
DNA binding and genomic targeting.
DNA Binding Properties of Tet30s CXXC Domain
To characterize the DNA binding activity of the mouse Tet3
CXXC domain, we prepared wild-type and mutant (C60A and
C72A) 182-amino acid (aa) recombinant GST-CXXC proteins
and performed gel mobility shift assays using oligonucleotides
containing all known cytosine C5 modifications (C, 5mC,
5hmC, 5fC, and 5caC). Unexpectedly, we observed that the
Tet3 CXXC domain binds more strongly to the oligonucleotide
containing 5caC than to normal cytosine (Figure 2B). Binding in
mobility shift assays was not detectable with 64-mer sequences
containing 5mC, 5hmC, or 5fC. Next, to quantify the binding af-
finities of Tet30s CXXC domain with both the unmodified DNA
and the 5caC-modified DNA, we used isothermal titration calo-
rimetry (ITC) to measure binding of the mouse Tet3 CXXC
domain (mTet3-CXXC, residues 51–97) to a 12-mer palindromic
DNA duplex centered around an unmodified CpG dinucleotide
(CCG DNA, GAATCCGGATTC) or a 5caCpG dinucleotide
(CcaCG DNA, GAATCcaCGGATTC; caC = 5-carboxyldeoxycyti-
dine) on both strands. The ITC analysis indicated that the mTet3-
CXXC domain binds to the unmodified CCG DNA with a Kd of
1.88 mM but binds to the CcaCG DNA with much higher affinity
(Kd of 0.56 mM) (Figure 2C). This 3.4-fold binding preference for
5caC over unmethylated DNA is greater than, for example, the
2-fold binding preference of the UHRF1 SET- and RING finger-
associated (SRA) domain for hemi- over unmethylated DNA (Rot-
tach et al., 2010). Thenwemeasured binding of themTet3-CXXC
domain to a 12-mer CmCG, CfCG, or ChmCG DNA duplex that
shows an identical sequence as the aforementioned CcaCG
DNA except for the replacement of 5caC with 5mC, 5fC,
or 5hmC. Our results showed that the mTet3-CXXC domain
binds to CmCG and CfCG with a Kd of 5.59 mM and 6.13 mM,ell Reports 14, 493–505, January 26, 2016 ª2016 The Authors 495
Figure 2. The CXXC Domain of Tet3 Is a
Specific Reader of 5-Carboxylcytosine at
50CCG Sequences
(A) Sequence of Tet-associated CXXC domains
frommouse (m), human (h), and Xenopus tropicalis
(xt). Cxxc4 is a separate protein associated with
Tet2. Amino acid positions and mutants are indi-
cated. Asterisks and dots indicate identical and
similar residues, respectively.
(B) Gel mobility shift assay of the mouse Tet3
CXXC domain and its mutant (C60A and C72A)
with oligonucleotides containing different cytosine
modifications.
(C) ITC of the Tet3 CXXC domain and oligo-
nucleotides containing 5caC or C at a CCG
sequence.
See also Figure S2.respectively, and evenmore weakly to ChmCG (Figures S2A and
S2B). Notably, when 5caC on one of the DNA strands was re-
placed with unmodified C, resulting in a hemi-carboxylated
DNA (hemi-CcaCG), we observed a slightly reduced binding af-
finity for mTet3-CXXC, with a Kd of 1.57 mM (Figures S2A and
S2B). Replacement of the unmodified C preceding 5caC with
A, T, or G also led to a reduced binding affinity (Figure S2C).
Together, these observations establish that the Tet3 CXXC
domain is a specific reader for 5caC DNA within the CcaCG
sequence. We examined the presence of 5caC at 50CCG se-
quences in vivo using published datasets in which 5caC was496 Cell Reports 14, 493–505, January 26, 2016 ª2016 The Authorsmapped at single-base resolution (Lu
et al., 2015). In this study, 48.5% of the
5caC bases were at 50ACG, 10.6% were
at 50TCG, 12.5% were at 50GCG, and
28.3% were at 50CCG. Therefore, CCG
accounts for a substantial fraction of
5caC. This particular sequence context
is overrepresented at CpG islands.
We also performed in vitro binding ex-
periments with Tet3FL or Tet3CDproteins
purified from HEK293T cells. We ob-
served that purified Tet3FL and Tet3CD
strongly bind to DNA irrespectively of
modifications (data not shown), most
likely because of the inherent DNA bind-
ing properties of the catalytic domain, as
shown previously for Tet2 (Hu et al.,
2013). TheDNAbinding property of Tet30s
CXXC domain to 5caC prompted us to
test a possible decarboxylase activity of
this domain that could directly remove
carboxyl groups from 5caC. However,
we did not observe any ability of Tet3-
CXXC to function as an ‘‘eraser’’ of
5-carboxyl groups on 5caC DNA using
in vivo and in vitro studies (Figures S2D
and S2E). In addition, the presence of
the CXXC domain of Tet3 did not affect
the cleavage activity of the DNA glycosy-lase TDG toward 5caC (Figure S2F), a preferred substrate of this
DNA glycosylase (He et al., 2011; Maiti and Drohat, 2011; Zhang
et al., 2012), nor did we find any direct interaction between the
Tet3 CXXC domain or Tet3FL and TDG (data not shown).
Structure of the Tet3 CXXC Domain in Complex
with 5caC
We then determined the crystal structure of mTet3-CXXC bound
to the 12-mer CcaCG DNA at 1.3-A˚ resolution (Figure 3; Table
S2). The structure reveals that the mTet3 CXXC domain, with a
crescent-like fold and two C4-type zinc clusters, interacts with
Figure 3. Complex of the Tet3 CXXC
Domain with DNA Containing 5caC
X-ray crystallography was used for structure
determination.
(A) Ribbon representation of the mTet3 CXXC
domain (light blue) bound to CcaCG DNA (wheat).
The zinc ions in the CXXC domain and the car-
boxylates in DNA are shown as green and red
spheres, respectively.
(B) Electrostatic surface representation of the
mTet3 CXXC domain bound to CcaCG DNA, with
positively charged, neutral, and negatively
charged areas shown in blue, gray, and red,
respectively.
(C) Schematic of intermolecular interactions be-
tween the Tet3 CXXC domain and CcaCG DNA,
with intermolecular hydrogen bonds shown by red
arrows.
(D–F) Specific hydrogen bonding interactions be-
tween side chains of the Tet3 CXXC domain and
the CcaC step in the DNA. The nitrogen, oxygen,
and phosphorous atoms are shown in dark blue,
red, and yellow, respectively. Water molecules are
shown in light purple.
See also Figure S3 and Table S2.the CcaCG DNA from both major and minor grooves (Figures 3A
and 3B). Association of mTet3-CXXC with CcaCG DNA involves
extensive protein-DNA contacts (Figure 3C). Of particular note,
we observed a number of interactions targeting the carboxylate
group of the 5caC nucleotides from both DNA strands. The
carboxylate of caC6 forms direct and water-mediated hydrogen
bonds with the side-chain amino group of mTet3 K88 and the
backbone amide of mTet3 I83, respectively (Figure 3D), whereas
the carboxylate of caC70 forms direct and water-mediated
hydrogen bonds with the side chain hydroxyl groups of mTet3
T80 and S74, respectively (Figure 3E). Other CcaCG base-spe-
cific interactions include the hydrogen bond between the side-
chain carbonyl oxygen of mTet3 Q82 and the N4 atom of
caC70 (Figure 3E), and the hydrogen bonds between the back-
bone carbonyl oxygen, amide nitrogen, and side-chain Nd1
atom of mTet3 H81 and the N4 atom of C5, O6 atom of G50Cell Reports 14, 493–505and N7 atom of G60, respectively (Fig-
ure 3F). Note that residues H81, Q82,
and K88 of mTet3 are highly conserved
throughout evolution (Figure 2A, red),
suggesting that the specific 5caC binding
is a common feature of the Tet-associ-
ated subfamily of CXXC domains. The
binding of mTet3-CXXC to CcaCG DNA
is further supported by a number of inter-
molecular interactions between the CXXC
domain and the phosphate backbone and
sugar moieties of DNA (Figures S3A
and S3B).
The CXXC domain of Xenopus tropica-
lis Tet3 (XtTet3) has been shown recently
to bind to unmodified and methylated
CpG sites in a different manner. ThemTet3 H81-equivalent residue in XtTet3 interacts with the central
CpG dinucleotide of the unmodified DNA (ACG DNA) but shifts
its binding to the preceding C,G pair when the cytosine in the
CpG dinucleotide becomes methylated (CmCG DNA) (Xu et al.,
2012). Consistent with that, our ITC analysis indicates that
mTet3-CXXC binds to the CmCGDNA sequence with a lower af-
finity than that for CCG and CcaCG DNA sequences (Figures
S2A and S2B). To understand the binding specificity of Tet3-
CXXC toward 5caC DNA, we compared the structure of
mTet3-CXXC-CcaCG DNA with those of XtTet3-CXXC-ACG
DNA and XtTet3-CXXC-CmCG DNA (Figures S3C and S3D).
The analysis indicates that the mTet3 H81-equivalent residues
from mTet3-CXXC-CcaCG and XtTet3-CXXC-CmCG com-
plexes both interact with the C,G pair preceding the central
(ca/m)CpG dinucleotides, thereby positioning the DNA mole-
cules in a similar fashion. However, it is apparent that the central, January 26, 2016 ª2016 The Authors 497
Figure 4. Isothermal Titration Calorimetry
Analysis of Different CXXC Domain Mutants
(A) Interaction of mutants with DNA contain-
ing CCG.
(B) Interaction of mutants with DNA containing
CcaCG.
(C) Summary of ITC data. N/A, not available.
See also Figure S4.(ca/m)CpG dinucleotides are recognized differently in the two
complexes. In the mTet3-CXXC-CcaCG complex, the central
caCpG dinucleotides are recognized by mTet3 T80, Q82, and
K88 through hydrogen bond interactions. By contrast, there is
no appreciable base-specific interaction involving the central
mCpG dinucleotides in the XtTet3-CXXC-CmCG complex, and
the corresponding protein residues are partially disordered (Xu
et al., 2012). Through superimposition of the structures of
mTet3-CXXC-CcaCG and XtTet3-CXXC-CmCG complexes, we
generated a model of an XtTet3-CXXC-CcaCG complex (Fig-
ure S3D). The strictly conserved residues Q91 and K97, equiva-
lent tomTet3 Q82 and K88, respectively, are both engaged in the
interactions with the caC nucleotides, whereas the mTet3 H81-
equivalent residue recognizes the preceding C,G pair (Fig-
ure S3D). Consistent with the modeling analysis, our ITC assays
indicate that the XtTet3-CXXC domain also strongly binds to
CcaCG, with a Kd of 1.30 mM (Figure S4). By contrast, it binds
to CCG and CmCG with a Kd of 2.58 mM and 9.00 mM, respec-
tively, which is in good agreement with what has been reported498 Cell Reports 14, 493–505, January 26, 2016 ª2016 The Authorsin a previous study (Xu et al., 2012). In
addition, we show that the XtTet3-CXXC
domain binds to CfCG and ChmC with a
Kd of 10.4 mM and 18.6 mM, respectively
(Figure S4). Therefore, we conclude that
the Tet3 CXXC domains across species
strongly bind to CcaCG DNA with a bind-
ing mode distinct from their binding to
either unmodified or other modified forms
of DNA. In fact, it is conceivable that 5caC
recognition is a conserved feature of the
Tet-associated CXXC domains given the
fact that the 5caC-interacting residues
of mTet3, including Q82 and K88, are
highly conserved within this family of
CXXC domains (Figure 2A). It is worth
noting that 5caC recognition by the Tet3
CXXC domain is also distinct from what
has been observed for the TDG-5caC
interaction (Zhang et al., 2012; Hashimoto
et al., 2013), in which the 5caC base is
flipped out of the DNA helix and inserted
into a pocket formed by TDG residues.
Mutations in the CXXC Domain
We then selected a number of CcaCG-in-
teracting residues for mutagenesis and
monitored their effect on the binding affin-
ities of mTet3-CXXC toward both CCGand CcaCGDNA by ITC (Figure 4). First, we observed that muta-
tion of H81 to alanine abolished the binding of the domain to both
CCGandCcaCGDNA, in agreement with our structural observa-
tion as well as a previous report showing that this residue is
essential for DNA binding (Xu et al., 2012). Second, the K88A
mutation led to >27-fold weaker binding toward CcaCG DNA
(Kd > 15 mM) but only a 3-fold weaker binding toward CCG
DNA (Kd = 5.32 mM) (Figures 4A–4C). These observations rein-
force the notion that residue K88, through direct interaction
with 5caC (Figure 3C), plays a key role in specific recognition be-
tween mTet3-CXXC and CcaCG DNA. Third, the mTet3-CXXC
T80A and Q82A mutations both led to a modest decrease in
binding affinity toward CcaCG DNA (Kd = 0.91 and 0.97 mM,
respectively) but an evenmore negligible change in binding affin-
ity toward CCG DNA (Kd = 1.79 and 2.38 mM, respectively),
consistent with the structural observations that both residues
contribute to binding to CcaCG DNA. We observed that Tet3 ac-
tivity to reactivate a methylated luciferase reporter gene was
increased only modestly (20%) when a Tet3 construct with a
Figure 5. Mapping of Tet3FL in Mouse Neu-
ral Progenitor Cells and Embryonic Brain-
Derived Neurons
(A) Distribution of peaks in the genome. TSS peaks
were defined as peaks between 0.5 and +0.5 kb
relative to the TSS (green). Extended promoter
peaks are located outside of the TSS and are be-
tween 0.5 kb and 2.5 kb up- or downstream of the
TSS (purple).
(B) Overlap of Tet3FL peaks with H3K4me3 and
histone H3 lysine 27 trimethylation (H3K27me3).
(C) Histogram of E15.5 brain Tet3FL distribution
near the TSS. The histogram shows the TSS ± 1 kb
on each side with 100 bp in each bin. The TSS is at
the center.
(D) Composite profile of Tet3FL (red), H3K4me3
(blue), and H3K27me3 (green) for mouse embryo
brain. The profile shows the gene body ± 5 kb. The
gene body was separated into 250 bins, whereas
the upstream and downstream 5 kb were sepa-
rated into 125 bins each.
(E) Gene ontology analysis of genes with Tet3FL
peaks near the TSS in E15.5 brain. Shown are
Molecular Signatures Database (MSigDB) analysis
results using GREAT.
(F) Enrichment of TFEB sequence motifs at Tet3FL
peaks.
(G) Expression levels of genes with and without
Tet3FL peaks at the TSS in E15.5 brain. Genes
with Tet3FL peaks are expressed at higher levels
(p < 2.2 3 10e16).
See also Figure S5 and Table S3.K88A mutation was used (data not shown). However, one needs
to take into account that only very low levels of 5caC are formed
under these conditions. Together, our mutational studies and
ITC assays lend strong support to our structural observations
for the mTet3-CXXC-CcaCG complex.
In Vivo Mapping of Tet3FL
To elucidate the role of Tet3FL in vivo, we developed a specific
antibody against its CXXC domain (Figure S5). This antibody
does not recognize the shorter isoforms of Tet3 (Figures S5A
and S5B) and detects a single band in neuronal cells and other
mouse tissues. Comparison with an antibody directed against
the C terminus of Tet3 (Active Motif) that recognizes all Tet3 iso-
forms shows that Tet3FL, because of its slightly lower mobility, is
likely the predominant Tet3 isoform in neuronal cells and in otherCell Reports 14, 493–505analyzedmouse tissues (Figures S5B and
S5C). Because Tet3FL is relatively abun-
dant in neuronal cells derived from differ-
entiating mouse ESCs, we first mapped
the distribution of Tet3FL in these
cells by chromatin immunoprecipitation
sequencing (ChIP-seq) using our in-
house antibody (Figure 5). The C-terminal
antibody did not work in ChIP-seq. One-
third of the peaks identified in neuronal
progenitor cells (NPCs) mapped very
close to transcription start sites (TSSs,0.5 to +0.5 kb) (Figure 5A; Table S3). These TSS peaks were
strong, whereas peaks in intra- or inter-genic regions were
much weaker and did not occur at CpG islands. To obtain addi-
tional support for Tet3FL localization in an in vivo setting, we
mapped Tet3FL in E15.5 embryonic mouse brain (containing
the cortex, ganglionic eminence, and hippocampus). This tissue
contains mostly neurons and few glial cells. Similar TSS peaks
were observed in NPCs and in embryonic brain (Figure 6; Fig-
ure S6) but their distribution was even more biased toward the
TSS in brain-derived neurons (Figure 5A; Table S3). About 42%
of the TSS peaks found in brain were also scores in NPCs.
Almost half of the genes having Tet3FL peaks near the TSS in
brain tissue are expressed preferentially in brain. The Tet3FL
peaks at the TSS strongly overlapped with histone H3 lysine 4
trimethylation (H3K4me3) peaks in embryonic mouse brain, January 26, 2016 ª2016 The Authors 499
Figure 6. Transcription Start Site-Centered
Tet3FL Peaks
ChIP-seq data show Tet3FL peaks at the TSSs in
NPCs (light blue) and mouse brain (dark blue). The
5mC patterns (shown as vertical bars representing
0%–100% methylation at individual CpG sites)
were obtained from whole-genome bisulfite
sequencing data of mouse ESCs (red) and NPCs
(blue) (Stadler et al., 2011).
(A) Genes related to the base excision repair
pathway.
(B) Genes important for lysosome structure and
function.
See also Figure S6 and Table S4.(Figure 5B). Histograms and composite profile analysis show
that the Tet3FL peaks are very precisely targeted to the TSS (Fig-
ures 5C and 5D). Tet3FL peaks overlap with the distribution of
H3K4me3 and appear to center within a nucleosome-free region,
as suggested by the dip in the H3K4me3 profile at the TSS (Fig-
ure 5D). Genes with a Tet3FL peak at the TSS have a higher
expression level than genes without a Tet3FL peak (Figure 5G),
although there are also many highly expressed genes with no
Tet3FL peak.
Gene ontology analysis using the Genomic Regions Enrich-
ment of Annotations Tool (GREAT) (McLean et al., 2010) revealed
that genes having Tet3FL peaks near the TSS in brain are signif-
icantly enriched in lysosome function, mRNA processing,
splicing, and base excision repair (Figure 5E; Tables S3 and
S4). Figure 6B and Figure S6A provide genome browser views
of several of the Tet3FL-targeted genes from the most promi-
nently enriched lysosome functional category. Strikingly, the
detailed analysis in Table S3 shows that 68 of 220 genes (31%)
with Tet3FL peaks at the TSS in brain-derived neurons are genes
implicated in lysosome function, protein degradation, and
autophagy.500 Cell Reports 14, 493–505, January 26, 2016 ª2016 The AuthorsAlthough the exact roles of Tet3FL in
regulating mRNA processing and in the
function of lysosomes are currently un-
known, the selective targeting of base
excision repair genes by Tet3FL provides
another important clue, suggesting that
active DNA demethylation is mediated
by the Tet3FL/BER pathway. Promoters
with strong Tet3FL peaks included
several genes of the core base excision
repair pathway, such as Apex1 (AP endo-
nuclease 1), Parp1 (poly-ADP-ribose po-
lymerase 1), and Tdg (Figure 6A; Table
S4). We also found peaks at the TSS of
Sae1, an E1-activating enzyme, as well
as at Pias4, which is a small ubiquitin-
like modifier (SUMO) ligase potentially
involved in SUMO-dependent activation
of Tdg (Figure 6A; Table S3; Hardeland
et al., 2002; Coey et al., 2014), as well
as Rad9, another binding partner and
activator of Tdg (Guan et al., 2007). Inaddition, we found a strong Tet3FL peak at the TSS of Stub1/
ChIP, an E3 ubiquitin ligase that regulates the function of the
base excision repair proteins XRCC1 and DNA polymerase b
(Parsons et al., 2008; Sobol, 2008). The Tdg-initiated base exci-
sion repair pathway is known to be critical for removal of 5caC
from DNA in the 5mC oxidation-demethylation cycle (He et al.,
2011). These Tet3FL-marked genes were upregulated upon dif-
ferentiation of mESC toward the neuronal lineage (Figure S6B).
During that transition, the total levels of 5caC are close to unde-
tectable (data not shown), making it unlikely that the Tet3FL
peaks we observed were at 5caC sites. Also, using anti-5caC
immunoprecipitation (IP) followed by PCR, we did not detect
any enrichment of 5caC at sequences with Tet3FL peaks near
the TSS of these genes (data not shown) suggesting that, if
5caC is formed there, then it is too transient to be detectable.
In the mouse brain, steady-state levels of 5caC are close to un-
detectable as well (Liu et al., 2013b). Whole-genome bisulfite
sequencing data of differentiatingmouse ESCs (mESCs) (Stadler
et al., 2011) have shown that genomic sequences near Tet3FL
peaks are largely unmethylated in ESCs and NPCs (Figure 6).
Interestingly, however, we observed an encroachment of 5mC
Figure 7. Model for the Biological Role of
Tet3FL in Maintaining the Unmethylated
State of CpG Islands through Anchoring
to 5caC
Tet3FL binds to unmethylated CpG sites at the
TSS of CpG islands of specific target genes.
Tethering of Tet3FL to transcription start sites
maintains these critical sequences in a methyl-
ation-free state. Binding of Tet3FL to its reaction
product 5-carboxylcytosine (ca) allows for highly
localized 5mC (m) oxidation in which Tet3 stays
bound to 5caC through the CXXC domain, pro-
moting rapid oxidation of adjacent, erroneously
introduced methyl groups.at sequences immediately surrounding the TSSs and Tet3FL
peaks in NPCs (Figure 6).
We used a motif-finding algorithm to identify sequence motifs
within Tet3FL peaks near the TSS. This motif search identified a
strong enrichment for a sequence recognized by the transcrip-
tion factor EB (TFEB), 50TCACGTGA (Figure 5F) (p < 6.5e-06).
TFEB motifs were found within 55% of all Tet3FL TSS peaksCell Reports 14, 493–505and were centered at those peaks. This
finding is consistent with the identification
of the lysosome pathway as most signifi-
cantly enriched for Tet3FL binding (Fig-
ure 5E) because TFEB is viewed as the
master regulator of autophagy and lyso-
somal genes (Palmieri et al., 2011; Set-
tembre et al., 2011).
DISCUSSION
In this study, we identified and character-
ized three different isoforms of the
mammalian 5mC oxidase Tet3. Tran-
scription of the oocyte-specific isoform
is initiated at a unique promoter and
CpG island. This CpG island contains
several binding sites for factors involved
in oocyte-specific transcription, including
NOBOX DNA binding element (NBE) and
E-box (Tsunemoto et al., 2008). Tet3o
lacks an N-terminal CXXC domain and,
therefore, is expected to be less targeted
to specific genomic sequences; e.g., to
CpG islands. Rather, this isoform may
participate in preferential genome-scale
oxidation of paternal pronuclear DNA in
zygotes (Gu et al., 2011; Iqbal et al.,
2011; Wossidlo et al., 2011). Specific
knockout of this oocyte-specific isoform
in the female germline will be required to
prove its key function in zygotic epige-
nome remodeling.
Tet proteins effectively produce 5hmC.
There are many unresolved issues; for
example, how and under what conditionsdo Tet proteins proceed beyond 5hmC formation to produce
5caC, resulting in DNA demethylation? Importantly, this study
identified the CXXC domain of Tet3 as a specific reader for
5caC. Our luciferase assays further suggest that binding of the
CXXC domain of Tet3FL to 5caC or C restricts its genome-wide
5mC oxidation capacity. Based on the data presented, we pro-
pose a model for Tet3FL function (Figure 7). Constitutive binding, January 26, 2016 ª2016 The Authors 501
of Tet3FL near the TSSs of unmethylated CpG islands suggests a
housekeeping function topreventmethylationofcriticalCpGsites
near the transcription start site (Figure 6). Upon inadvertent intro-
duction of 5mC by a DNA methyltransferase, Tet3FL oxidizes
5mC to 5caC. The high affinity of the CXXC domain of Tet3FL to
5caC causes Tet3FL to become even more tightly bound to
genomic regions in which 5mC has been oxidized to 5caC.
Through this anchoring mechanism, the catalytic domain of
Tet3 is thenable to rapidly oxidize additional 5mCbases in the im-
mediate vicinity of the first oxidized base, resulting in a highly
effective, localized 5mC oxidation reaction to preserve the integ-
rity of critical unmethylatedCpG islands at TSS regions (Figure 7).
Our model describes an anchoring mechanism whereby two
different domains of the same protein can be engaged (the cata-
lytic domain and the CXXC domain, which binds to the reaction
product of Tet3FL activity). This theme is becoming quite com-
mon in chromatin regulators, which often contain writer and
reader domains either within the same polypeptide or within a
complex (Hassan et al., 2002; Lan et al., 2007; Hansen et al.,
2008; Zhang et al., 2008; Margueron et al., 2009; Klein et al.,
2014; Dumesic et al., 2015; Liu et al., 2015; Torres et al., 2015).
The purpose of these dual domains is generally viewed as
anchoring the modifier to its preferred sites of activity.
Gene ontology (GO) analysis suggests that Tet3FL preferen-
tially targets genes functioning in lysosome pathways, mRNA
processing, and base excision repair (Figure 5E). The limited
number and selective nature of the Tet3FL peaks we observed
suggest that Tet3FL is targeted to these loci specifically either
based on DNA sequence preference, the chromatin environ-
ment, or interaction with transcription factors. A fraction of
Tet3 in neurons may not contain the CXXC domain. A recent
study has described an interaction of the short form of Tet3
(Tet3s) with certain transcription factors, including RE1-silencing
transcription factor (REST) (Perera et al., 2015), although the
genomic location of Tet3s was not mapped in that study. We
show here that Tet3FL is the predominant Tet3 protein isoform
in neurons (Figure S5B). The exact targeting mechanisms of
Tet3FL remain to be determined. For the lysosomal and auto-
phagy genes, our motif analysis of Tet3FL peaks uncovered
TFEB as a likely factor involved in Tet3FL recruitment (Figure 5F).
Of particular significance, preferential binding of Tet3FL was
observed at transcription start sites of genes functioning in
base excision repair. This fact suggests a regulatory function
of Tet3FL in promoting the expression of factors that process
the final DNA oxidation product of Tet activity, 5caC, including
Tdg and apurinic/apyrimidinic (AP) endonuclease, which implies
the existence of a Tet3FL-dependent regulatory feedforward
pathway for active, base excision repair-associated DNA
demethylation.
Interestingly, mapping of Myc-tagged Idax/Cxxc4, which pre-
sumably is in a complex with Tet2, revealed partially similar GO
categories, with mRNA splicing as the most significantly en-
riched one (Ko et al., 2013). The exact role of Tet proteins and/
or their associated 5mC oxidation products in RNA splicing is
currently not understood, although it has been found in some
studies that 5hmC is enriched at exon-intron boundaries, sug-
gesting a mechanistic link between 5hmC and splicing (Khare
et al., 2012; Wen et al., 2014).502 Cell Reports 14, 493–505, January 26, 2016 ª2016 The AuthorsThe association of Tet3FL with genes regulating lysosome
function is particularly intriguing and is of potential significance
for neurodegenerative diseases. A large fraction (31%) of all
Tet3FL peaks in brain-derived neurons was localized at the TSS
ofgenes functioning in lysosomalandautophagypathways (Table
S3). The genes identified in the category ‘‘lysosome’’ included
Ctsd (cathepsin D), Gba (glucocerebrosidase), Hexa (hexo-
saminidase A), Lamp1 (lysosomal-associated membrane pro-
tein 1), Sumf1 (sulfatase modifying factor 1), Tpp1 (tripeptidyl
peptidase I), Cln3 (ceroid-lipofuscinosis, neuronal 3), Atg3 (auto-
phagy related 3), and a number of others (Figure 6; Figure S6; Ta-
bles S3 andS4). Several of these genes are commonlymutated in
neuronal ceroid lipofuscinoses (a subgroup of lysosome storage
diseases), a set of brain disorders caused by defects in either sol-
uble enzymes or membrane-associated structural proteins that
result in dysfunction of lysosomes (Shacka, 2012). Mutations in
these genes are often associated with neurodegeneration
because of failure to degrade sphingolipids and specific neuro-
peptides. Lysosomal activities are rate-limiting for degradation
of aged or damaged proteins, and diminished lysosome function
has been linked to other neurodegenerative diseases, including
Parkinson’s disease (Schneider and Zhang, 2010; Gan-Or et al.,
2015). Heterozygous mutations in b-glucocerebrosidase (GBA)
are the strongest genetic risk factor for Parkinson’s disease
known to date (Sidransky et al., 2009; Scho¨ndorf et al., 2014).
Aging brains exhibit decreased lysosomal function (Cuervo and
Dice, 2000). Further studies are required to understand why
Tet3FL is particularly prevalent at the TSSs of this unique group
of genes, whether Tet3FL maintains long-term expression of
these genes by repairing methylation errors, and how this control
might be disabled during organismal aging, potentially contrib-
uting to neurodegenerative diseases. The existence of a
Tet3FL-mediated active 5mC removal process may be of special
significance for post-mitotic neurons, inwhich replication-depen-
dent dilution of erroneously deposited 5mC is not an option.EXPERIMENTAL PROCEDURES
Mouse oocytes and brain tissue were obtained under institutional review
board-approved protocols. The Tet3 isoforms were identified through RT-
PCR, and their activities were examined using transfection assays, luciferase
reporter assays, and dot blots. The interaction of Tet3-CXXC with DNA was
determined using electrophoretic mobility shift assays (EMSAs) and ITC
assays. The structure of mTet3-CXXC in complex with 5caC DNA was deter-
mined using X-ray crystallography. Mapping of Tet3FL in mouse neural pro-
genitor cells and embryonic brain-derived neurons was performed using the
ChIP sequencing method.
More details can be found in the Supplemental Experimental Procedures.ACCESSION NUMBERS
The accession number for the ChIP-seq data reported in this paper is GEO:
GSE56821. The accession number for the structural data reported in this paper
is PDB: 5EXH.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four tables and can be found with this article online at http://
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